AI is reshaping drug discovery and healthcare innovation. Exciting developments include the launch of Insilico Medicine’s Nach01 foundation model on AWS Marketplace to accelerate generative chemistry. Novel AI-driven platforms like FutureHouse’s Robin demonstrate autonomous scientific hypothesis generation and target identification, notably for age-related macular degeneration. Northwestern researchers unveiled generative AI tools to identify gene combinations underlying complex diseases, illustrating AI’s growing role in decoding multifaceted biological systems and expediting therapeutic discovery.